Equities

XSpray Pharma AB (publ)

  • Add to watchlist
  • Add to portfolio
  • Add an alert

XSpray Pharma AB (publ)

Actions
Health CarePharmaceuticals and Biotechnology
  • Price (SEK)25.20
  • Today's Change1.05 / 4.35%
  • Shares traded40.65k
  • 1 Year change-20.08%
  • Beta0.0775
Data delayed at least 15 minutes, as of Feb 12 2026 17:00 GMT.
More ▼
Notice
Important Notice
Please note that effective 5th February, 2026 the Financial Times will no longer publish or present securities from the Nairobi Stock Exchange.

Financials data is unavailable for this security.

Cash flow in SEKView more

In 2024, XSpray Pharma AB (publ) increased its cash reserves by 25.21%, or 41.93m. Cash Flow from Financing totalled 306.11m or -- of revenues. In addition the company used 222.37m for operations while cash used for investing totalled 42.14m.
Cash flow per share-5.71
Price/Cash flow per share--
Book value per share15.37
Tangible book value per share3.16
More ▼

Balance sheet in SEKView more

XSpray Pharma AB (publ) appears to have a strong balance sheet with enough cash in the capital structure to pay down 100% of the liabilities.
Current ratio6.72
Quick ratio5.93
Total debt/total equity0.232
Total debt/total capital0.1883
More ▼
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.